Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen Recruiting Phase 3 Trials for Meningococcal Infection (Healthy Volunteers) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04490018Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents